SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE) — FDA Approval ANDA078298 (HIKMA PHARMS)
SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE) — FDA Approval ANDA078298 (HIKMA PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SUMATRIPTAN SUCCINATE; Active ingredients: SUMATRIPTAN SUCCINATE; Application number: ANDA078298.
| Brand name | SUMATRIPTAN SUCCINATE |
|---|---|
| Active ingredients | SUMATRIPTAN SUCCINATE |
| Application number | ANDA078298 |
| Sponsor | HIKMA PHARMS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20130521 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →